ARTICLE

Sulfoxide Analogs of TAK-875 as G Protein Coupled Receptor 40 Agonists: Synthesis, Determination of Absolute Configuration and Biological Activity

  • Yan Yugang ,
  • Chen Xueying ,
  • Yang Xinying ,
  • Xu Wenfang ,
  • Zhang Yingjie
Expand
  • a. Institute of Medicinal Chemistry, School of Pharmacy, Shandong University, Ji'nan 250012;
    b. Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital, Shandong University, Ji'nan 250012;
    c. Institute of Pharmaceutical Analysis, School of Pharmacy, Shandong University, Ji'nan 250012

Received date: 2016-12-12

  Revised date: 2017-02-16

  Online published: 2017-03-03

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 21302111, 81373282), the Major Project of Science and Technology of Shandong Province (No. 2015ZDJS04001), the Young Scholars Program of Shandong University (No. 2016WLJH33).

Abstract

G protein coupled receptor 40 (GPR40) is a potential target for treatment of type 2 diabetes. Herein, the well-known GPR40 agonist TAK-875 (compound 1) was synthesized as a positive control. Besides, an epimeric mixture 11, which was the sulfoxide analog of compound 1 was also synthesized. The following chiral HPLC separation of 11 led to optically pure compounds 12 (S,S, 100.0% de) and 13 (R,S, 100.0% de), of which the absolute configurations were determined by circular dichroism spectra analysis. In vitro biological activity evaluation results showed that the GPR40 agonistic potency of epimeric mixture 11 (EC50=77.5 nmol·L-1) and its two optically pure epimers (12, EC50=76.1 nmol·L-1; 13, EC50=114.0 nmol·L-1) were comparable to that of compound 1 (EC50=84.3 nmol·L-1), which was rationalized by docking analysis. Compounds 12 and 13 warrant further drug-like property evaluation due to their promising potency and novel structures.

Cite this article

Yan Yugang , Chen Xueying , Yang Xinying , Xu Wenfang , Zhang Yingjie . Sulfoxide Analogs of TAK-875 as G Protein Coupled Receptor 40 Agonists: Synthesis, Determination of Absolute Configuration and Biological Activity[J]. Chinese Journal of Organic Chemistry, 2017 , 37(4) : 858 -865 . DOI: 10.6023/cjoc201612041

References

[1] The Diabetes Education Consultative Section (DECS); Jeannete, A.; Nizar, A. B.; Maria, H. H.; Sir, M. H.; Ute, L.; Dianna, M.; Farheen, O.; Chris, P.; Nasheeta, P.; Andrey, P.; Mohammad, M. A.S.; Elena, S.; Teresa, T.; Juliet, U. S.; Zhang, X.; Samrawit, Y.; George, A.; Peter, B.; Juliana, C.; Adel, A. E. S.; Beatriz, Y. J.; Ji, L.; Kerry, L.; Viswanathan, M.; Lyudmil, N.; Graham, O.; Lorenzo, P.; Marie, A. T.; Sarah, H. W.; Paul, Z.; Bernard, Z. IDF Diabetes Atlas, 7th ed.; International Diabetes Federation, 2015; http://www.diabetesatlas.org.
[2] Choi, Y. J.; Shin, D.; Lee, J. Y. Arch. Pharm. Res. 2014, 37, 435.
[3] Itoh, Y.; Kawamata, Y.; Harada, M.; Kobayashi, M.; Fujii, R.; Fukusumi, S.; Ogi, K.; Hosoya, M.; Tanaka, Y.; Uejima, H.; Tanaka, H.; Maruyama, M.; Satoh, R.; Okubo, S.; Kizawa, H.; Komatsu, H.; Matsumura, F.; Noguchi, Y.; Shinohara, T.; Hinuma, S.; Fujisawa, Y.; Fujino, M. Nature 2003, 422, 173.
[4] Latour, M. G.; Alquier, T.; Oseid, E.; Tremblay, C.; Jetton, T. L.; Luo, J.; Lin, D. C.; Poitout, V. Diabetes 2007, 56, 1087.
[5] Lu, H.; Fei, H.; Yang, F.; Zheng, S.; Hu, Q.; Zhang, L.; Yuan, J.; Feng, J.; Sun, P.; Dong, Q. Bioorg. Med. Chem. Lett. 2013, 23, 2920.
[6] Tikhonova, I. G.; Sum, C. S.; Neumann, S.; Thomas, C. J.; Raaka, B. M.; Costanzi, S.; Gershengorn, M. C. J. Med. Chem. 2007, 50, 2981.
[7] Briscoe, C. P.; Tadayyon, M.; Andrews, J. L.; Benson, W. G.; Chambers, J. K.; Eilert, M. M.; Ellis, C.; Elshourbagy, N. A.; Goetz, A. S.; Minnick, D. T.; Murdock, P. R.; Sauls, H. R., Jr.; Shabon, U.; Spinage, L. D.; Strum, J. C.; Szekeres, P. G.; Tan, K. B.; Way, J. M.; Ignar, D. M.; Wilson, S.; Muir, A. I. J. Biol. Chem. 2003, 278, 11303.
[8] Shapiro, H.; Shachar, S.; Sekler, I.; Hershfinkel, M.; Walker, M. D. Biochem. Biophys. Res. Commun. 2005, 335, 97.
[9] Fujiwara, K.; Maekawa, F.; Yada, T. Am. J. Physiol. Endocrinol. Metab. 2005, 289, E670.
[10] Tan, C. P.; Feng, Y.; Zhou, Y. P.; Eiermann, G. J.; Petrov, A.; Zhou, C.; Lin, S.; Salituro, G.; Meinke, P.; Mosley, R.; Akiyama, T. E.; Einstein, M.; Kumar, S.; Berger, J. P.; Mills, S. G.; Thornberry, N. A.; Yang, L.; Howard, A. D. Diabetes 2008, 57, 2211.
[11] Li, H.; Long Y. Q. Chin. J. Org. Chem. 2016, 36, 736 (in Chinese).
(李鹤, 龙亚秋, 有机化学, 2016, 36, 736.)
[12] Negoro, N.; Sasaki, S.; Mikami, S.; Ito, M.; Suzuki, M.; Tsujihata, Y.; Ito, R.; Harada, A.; Takeuchi, K.; Suzuki, N.; Miyazaki, J.; Santou, T.; Odani, T.; Kanzaki, N.; Funami, M.; Tanaka, T.; Kogame, A.; Matsunaga, S.; Yasuma, T.; Momose, Y. ACS Med. Chem. Lett. 2010, 1, 290.
[13] Negoro, N.; Sasaki, S.; Mikami, S.; Ito, M.; Tsujihata, Y.; Ito, R.; Suzuki, M.; Takeuchi, K.; Suzuki, N.; Miyazaki, J.; Santou, T.; Odani, T.; Kanzaki, N.; Funami, M.; Morohashi, A.; Nonaka, M.; Matsunaga, S.; Yasuma, T.; Momose, Y. J. Med. Chem. 2012, 55, 3960.
[14] Defossa, E.; Wagner, M. Bioorg. Med. Chem. Lett. 2014, 24, 2991.
[15] Liu, J. J.; Wang, Y.; Ma, Z.; Schmitt, M.; Zhu, L.; Brown, S. P.; Dransfield, P. J.; Sun, Y.; Sharma, R.; Guo, Q.; Zhuang, R.; Zhang, J.; Luo, J.; Tonn, G. R.; Wong, S.; Swaminath, G.; Medina, J. C.; Lin, D. C.; Houze, J. B. ACS Med. Chem. Lett. 2014, 5, 517.
[16] Takano, R.; Yoshida, M.; Inoue, M.; Honda, T.; Nakashima, R.; Matsumoto, K.; Yano, T.; Ogata, T.; Watanabe, N.; Hirouchi, M.; Yoneyama, T.; Ito, S.; Toda, N. ACS Med. Chem. Lett. 2015, 6, 266.
[17] Guo, D. Y.; Li, D. W.; Ning, M. M.; Dang, X. Y.; Zhang, L. N.; Zeng, L. M.; Hu, Y. H.; Leng, Y. Biochem. Biophys. Res. Commun. 2015, 466, 740.
[18] Ma, Z.; Lin, D. C.; Sharma, R.; Liu, J.; Zhu, L.; Li, A. R.; Kohn, T.; Wang, Y.; Liu, J. J.; Bartberger, M. D.; Medina, J. C.; Zhuang, R.; Li, F.; Zhang, J.; Luo, J.; Wong, S.; Tonn, G. R.; Houze, J. B. Bioorg. Med. Chem. Lett. 2016, 26, 15.
[19] Tanaka, H.; Yoshida, S.; Minoura, H.; Negoro, K.; Shimaya, A.; Shimokawa, T.; Shibasaki, M. Life Sci. 2014, 94, 115.
[20] Sunil, V.; Verma, M. K.; Oommen, A. M.; Sadasivuni, M.; Singh, J.; Vijayraghav, D. N.; Chandravanshi, B.; Shetty, J.; Biswas, S.; Dandu, A.; Moolemath, Y.; Venkataranganna, M. V.; Somesh, B. P.; Jagannath, M. R. BMC Pharmacol. Toxicol. 2014, 15, 19.
[21] Lead GPR40 agonist bites the dust Nat. Rev. Drug Discovery 2014, 13, 91.
[22] Srivastava, A.; Yano, J.; Hirozane, Y.; Kefala, G.; Gruswitz, F.; Snell, G.; Lane, W.; Ivetac, A.; Aertgeerts, K.; Nguyen, J.; Jennings, A.; Okada, K. Nature 2014, 513, 124.
[23] McGarry, J. D.; Dobbins R. L. Diabetologia 1999, 42, 128.
[24] Yamano, M.; Goto, M.; Kajiwara, T.; Maeda, H.; Konishi, T.; Sera, M.; Kondp, Y.; Yamasaki, S. WO 2012/111849, 2012 [Chem. Abstr. 2012, 157, 410099].
[25] Cho, H.; Plapp, B. V. Biochemistry 1998, 37, 4482.
[26] Kang, X. S.; Chen, Z. H. WO 2015/024526, 2015 [Chem. Abstr. 2015, 162, 353242].

Outlines

/